Anti-Human CD40LG Recombinant Antibody
-
产品编号
YR1017
-
别名
科研级 Ruplizumab ( 卢利珠单抗 ), Anti-CD40LG Recombinant Antibody, Research Grade Ruplizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Ruplizumab ( 卢利珠单抗 ), Anti-CD40LG Recombinant Antibody, Research Grade Ruplizumab |
Catalog Number | YR1017 |
Molecular Name | Ruplizumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms, while another study only found thrombocytopenia. |
CAS Number | 220651-94-5 |
Application | IF, IP, Neut, FuncS, ELISA, FCM |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Molecular Weight | 145.45 kDa |
Target | CD40LG[Homo sapiens] |